Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in the United States. They focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.
Focus Areas
Investment Types
Notable Investments
